OncoAlert
M

Ovarian Cancer: Setting a New Standard of Care

By OncoAlert FEATURING Mansoor Raza Mirza
By OncoAlert FEATURING Mansoor Raza Mirza
1,095 views
March 1, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

20:09
AstraZeneca Oncology

Management Strategies for Anemia in First-line Maintenance Therapy f…

Feat. D. Czel, C. Arn

Featured Video

19:51
AstraZeneca Oncology

Management Strategies for Fatigue and Asthenia in First-line Mainten…

Feat. D. Czel, C. Arn

Related Content

AUTOPLAY
27:04
Fengting Yan

Cancer Screening Molecular Tools

06:07
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

Feat. M. Raza Mirza
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
11:15
Total Health

2024 Updates in Ovarian Cancer

Feat. T. Tillmanns
06:50
Fengting Yan

Year in Review: Ovarian Cancer

25:10
Yale School of Medicine

Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …

Feat. M. Minkin, E. Ratner
15:14
Brian Slomovitz

Update in Vulvar and Vaginal Cancer

06:23
Total Health

Recent Highlights in Ovarian Cancer

Feat. B. Slomovitz
05:20
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Impact of Immune Checkpoint Inhibition on…

Feat. E. Buchbinder
18:16
Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "Antibody-Drug Conjugates in Ovarian Cancer…

Feat. J. Kurtz
05:09
Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "Final OS Data of Relacorilant, a Selective …

Feat. N. Colombo
05:32
Insights from 2023 ESMO Asia Annual Meeting

LARA Trial: Preliminary Efficacy of Pembro + Lenvatinib in Recurrent…

Feat. N. Ngoi
23:35
Kathleen Moore

How to Select the Best Maintenance Treatment in Patients With Ovaria…

14:05
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "ICON8B: GCIG Phase 3 Randomised Trial Comp…

Feat. A. Clamp
15:45
Michael Birrer

Defining Platinum Resistance in Ovarian Cancer

09:42
Erin Crane

Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer

17:06
Ovarian Cancer Midwest Focus, University of Minnesota

Novel ADCs in Ovarian Cancer: A New Treatment Modality

Feat. S. Lheureux
10:27
Robert McBane

2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Pr…

11:37
UCLA Health

Recurrent Cervical Cancer Updates

Feat. R. Salani
08:37
Fred Hutchinson Cancer Center

Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer: D…

Feat. K. Banda